Sensyne Health PLC - clinical AI company - Launches its Sense system in the UK, developed in partnership with Microsoft Corp and its health cloud technology, as part of an existing strategic partnership between the two organisations. Sensyne has signed its first agreement with Chelsea & Westminster Hospital NHS Foundation Trust for an algorithm produced by the Sense system. The algorithm, called Syne-Cov, aims to provide more personalised care for patients with Covid-19, integrating data into an existing real-time dashboard allowing clinicians to augment their clinical decisions with near real time risk prediction for three outcomes: risk of ICU admission, the need for mechanical ventilation and in-hospital mortality. Other SYNE algorithms for different conditions are currently being developed, Sensyne said.
Current stock price: 80.60 pence
Year-to-date change: up 22%
By Evelina Grecenko; evelinagrecenko@alliancenews.com
Copyright 2020 Alliance News Limited. All Rights Reserved.